Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous CD34+ cells transfected with lentiviral vector containing the Wiskott-Aldrich syndrome protein gene

EU orphan designation number: EU/3/12/998   
Active ingredient: Autologous CD34+ cells transfected with lentiviral vector containing the Wiskott-Aldrich syndrome protein gene
Indication: Treatment of Wiskott-Aldrich syndrome
Sponsor: Fondazione Telethon
Via Carlo Spinola 16, 00154 Rome, Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/06/2012 Centralised Orphan - Designation EMA/OD/014/12 (2012)3842 of 06/06/2012
11/10/2013 Other procedure